Unjha Formulations Limited (BOM:531762)
India · Delayed Price · Currency is INR 19.26
-0.74 (-3.70%)
At close: May 26, 2026
Unjha Formulations Market Cap
Unjha Formulations has a market cap or net worth of 86.47 million as of May 27, 2026. Its market cap has decreased by -16.63% in one year.
Market Cap
86.47M
Enterprise Value
70.03M
Revenue
157.49M
Ranking
n/a
PE Ratio
12.29
Stock Price
19.26
Market Cap Chart
Since May 25, 2005, Unjha Formulations's market cap has increased from 51.62M to 86.47M, an increase of 67.53%. That is a compound annual growth rate of 2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 86.47M | -22.80% |
| Dec 31, 2025 | 112.01M | -17.68% |
| Dec 31, 2024 | 136.07M | 86.43% |
| Dec 29, 2023 | 72.99M | 6.19% |
| Dec 30, 2022 | 68.73M | 42.04% |
| Dec 31, 2021 | 48.39M | 19.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Norris Medicines | 141.91M |
| Parmax Pharma | 137.34M |
| Emmessar Biotech & Nutrition | 130.90M |
| Colinz Laboratories | 122.20M |
| Shamrock Industrial Company | 121.74M |
| Ortin Global | 111.81M |
| Beryl Drugs | 96.41M |
| Ganga Pharmaceuticals | 70.94M |